Oramed Pharmaceuticals
ORMP
ORMP
21 hedge funds and large institutions have $1.85M invested in Oramed Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
75% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 8
95% less call options, than puts
Call options by funds: $1K | Put options by funds: $20K
Holders
21
Holding in Top 10
–
Calls
$1K
Puts
$20K
Top Buyers
| 1 | +$43K | |
| 2 | +$14.3K | |
| 3 | +$3K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.07K |
Top Sellers
| 1 | -$166K | |
| 2 | -$154K | |
| 3 | -$143K | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$116K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$103K |